Italia markets open in 4 hours 7 minutes

Dow Jones
38.686,32
+574,82(+1,51%)
Nasdaq
16.735,02
-2,08(-0,01%)
Nikkei 225
38.849,65
+361,75(+0,94%)
EUR/USD
1,0857
+0,0002(+0,02%)
Bitcoin EUR
62.996,68
+682,31(+1,09%)
CMC Crypto 200
1.478,75
+50,18(+3,51%)

NVCR Jan 2026 25.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

7,60

0,00

(0,00%)

In data: 03:22PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in